Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Events / Business / Health Catalyst divests Vitalware to...
Business divestiture

Health Catalyst divests Vitalware to Med-Metrix

Analysis based on 12 articles · First reported Jun 04, 2026 · Last updated Jun 08, 2026

Sentiment
60
Attention
4
Articles
12
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The divestiture by Health Catalyst is expected to positively impact its stock price due to a strengthened balance sheet and increased financial flexibility for AI investments. Med-Metrix's acquisition of Vitalware could lead to growth in its revenue cycle management business.

Healthcare Technology Financial Services
Event Summary

Health Catalyst announced a definitive agreement to divest its Vitalware business unit to Med-Metrix for $147 million in cash. This strategic move allows Health Catalyst to sharpen its focus on core technology and AI investments within healthcare intelligence. The net proceeds from the divestiture, combined with cash on hand, are planned to fully repay and terminate Health Catalyst's existing senior secured term loan facility of approximately $160 million. Med-Metrix, a technology-enabled revenue cycle management company, will acquire Vitalware, a best-in-KLAS leader in mid-revenue cycle solutions. The transaction is expected to close in 2026, subject to regulatory approvals.

Key Actions
95 Health Catalyst signed agreement to divest Vitalware
95 Med-Metrix acquire Vitalware
85 Health Catalyst repay and terminate
70 Harvest Partners supported acquisition Med-Metrix
10 Health Catalyst filed Form 8-K United States — United States Securities and Exchange Commission
Entities Involved
priv
Health Catalyst
Health Catalyst is divesting its Vitalware business unit to focus on core technology and AI investments, expecting to strengthen its balance sheet and improve financial flexibility by repaying its senior secured term loan facility.
Importance 100 Sentiment 70
priv
Med-Metrix
Med-Metrix is acquiring Vitalware for $147 million, which will expand its offerings in technology-enabled revenue cycle management and allow it to invest more deeply in the business.
Importance 90 Sentiment 60
priv
Vitalware
Vitalware, a mid-revenue cycle business, is being divested by Health Catalyst to Med-Metrix for $147 million, allowing it to be further developed under a company focused on revenue cycle management.
Importance 80 Sentiment 50
priv
Harvest Partners
Harvest Partners, a private equity firm, backs Med-Metrix and supports its strategic acquisition of Vitalware. This acquisition aligns with Harvest Partners' strategy of financing growth opportunities for its portfolio companies.
Importance 70 Sentiment 60
per
David Joseph
David Joseph, Founder and CEO of Med-Metrix, expressed excitement about welcoming Vitalware, highlighting the acquisition's role in expanding Med-Metrix's ability to deliver financial outcomes.
Importance 50 Sentiment 60
per
Robert Wright
Robert Wright, Co-President of Med-Metrix, views Vitalware as a natural extension of their platform, which will help providers improve reimbursement accuracy and manage compliance risk.
Importance 50 Sentiment 60
loc
Canada — Alberta
Canada — Alberta, CEO of Health Catalyst, expressed that the divestiture is a significant step forward for Health Catalyst, allowing the company to concentrate on its core business areas.
Importance 40 Sentiment 50
priv
A&M Capital Partners
A&M Capital Partners is a backer of Med-Metrix, supporting its acquisition of Vitalware. This indicates their continued investment in Med-Metrix's growth.
Importance 40 Sentiment 50
per
Lucas Rogers
Lucas Rogers, Partner at Harvest Partners, affirmed support for Med-Metrix's strategic acquisition, noting that Vitalware will enhance Med-Metrix's mid-revenue cycle capabilities and growth strategy.
Importance 40 Sentiment 60
stock
Raymond James Financial
Raymond James served as the exclusive financial advisor for Health Catalyst in this divestiture.
Importance 20 Sentiment 50
priv
Latham & Watkins
Latham & Watkins LLP served as outside legal counsel for Health Catalyst during the transaction.
Importance 20 Sentiment 50
govactor
United States — United States Securities and Exchange Commission
Health Catalyst filed a Form 8-K with the United States — United States Securities and Exchange Commission regarding the divestiture, providing additional details about the transaction.
Importance 10 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.